About AlphaScience
  Produktliste     Über AlphaScience     Infos & Events     AGBs & Imprint  
Our Team
Our Vision
Our Mission
Distribution Service
Marketing Service
Technical Service
Product Partnering
The Location
Our Network
Events
Our Partners
B2B Projects
Export List
Imprint & Disclaimer
Allgemein:
Startseite
Aktuelles / News
Kontakt / Contact
B2B Projekte
Impressum
Sitemap

Product Partnering

International developments in Life-Science have shown that it takes far more to make a profitable company than just promising research results or product ideas. The timescale and capital requirements for a product to reach maturity and marketability had frequently been greatly underestimated by both entrepreneurs and investors.

What does an enterprise do, when a product comes out of the R&D department, has reached marketability status, patents have been granted, licensing agreements could be made, or a cooperation could be set up?
If only 30% of Biotech companies have their own distribution network, mostly employ less than 10 people, and 88% of enterprises find their focus in research activities, then the logical consequence is:
- Nobody knows about the extraordinary competence in the respective field
- Nobody knows that a company is offering or looking for cooperation
- Nobody is able to successfully market a newly developed product
- Nobody is able to understand innovative ideas
AlphaScience can plan, execute and control all necessary measures for the successful and customer-oriented marketing of new products, services or licenses.

AlphaScience wants to act beyond the usual services offered by distributors in the following areas:
- Development of a long term distribution plan
- Constant two-way information exchange
- Regular reports on the current market situation
- Creation of product and field studies for strategic analyses of the partners
- Collection and documentation of complaints
- Complaint handling according to legal requirements

Additionally we want to add products and services to our portfolio which would be discontinued upon company mergers and acquisitions, or due to portfolio culling. These should then be offered as for good laboratory praxis still important niche products to interested parties.


Druckbare Version / Printable Version